Selective Oligonucleotide Amplification via Rolling Circle Replication

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for synthesizing oligonucleotides on a large scale are inefficient and costly, resulting in low quantities of high-quality oligonucleotides, which are insufficient for constructing two- and three-dimensional nanoscale DNA structures, and often contain truncated sequences that interfere with the folding process.

Innovation Solution

The use of rolling circle replication and circle-to-circle amplification methods to selectively amplify specific oligonucleotides from a chip-synthesized oligonucleotide pool, producing high-quality oligonucleotides in larger quantities by consecutive rounds of amplification, which can reach up to a billion-fold amplification, and are suitable for use as staple strands in DNA nanostructures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chip-based parallel synthesis is used to produce oligonucleotides, then synthesis capacity is improved, but the quantity of oligonucleotides produced is insufficient for DNA nanostructure assembly

Engineering Contradiction:
Improvesynthesis capacityVSAvoidquantity of oligonucleotides
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent uses rolling circle replication to copy oligonucleotide sequences from chip-synthesized templates, generating billions of copies of each oligonucleotide sequence. This copying process transforms the limited quantity of chip-synthesized oligonucleotides (1 pmol total) into sufficient quantities (micromolar concentrations) for DNA nanostructure assembly

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent performs preliminary chip-based synthesis to create template oligonucleotides with unique sequences, then uses these templates to guide the subsequent rolling circle replication process. This preliminary action ensures that only the desired oligonucleotide sequences are amplified in the subsequent steps

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If conventional amplification methods are used, then oligonucleotide quantity is improved, but manufacturing precision deteriorates due to truncated sequences

Engineering Contradiction:
Improvequantity of oligonucleotidesVSAvoidoligonucleotide quality
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent extracts only the full-length, high-quality oligonucleotide sequences through rolling circle replication, leaving behind truncated sequences and synthesis byproducts. The method selectively amplifies complete oligonucleotide sequences from the chip-synthesized pool, ensuring high manufacturing precision

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses disposable chip-synthesized template oligonucleotides that are consumed during the rolling circle replication process. These templates are sacrificed to generate large quantities of high-quality product oligonucleotides, separating the low-cost template function from the high-value product

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Quantity of substance

If large quantities of oligonucleotides are synthesized conventionally, then quantity is improved, but cost increases and quality decreases

Engineering Contradiction:
Improvequantity of oligonucleotidesVSAvoidcost-effectiveness
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

Instead of synthesizing each oligonucleotide individually or in large pools, the patent copies specific sequences from a small library of chip-synthesized templates through rolling circle replication. This copying approach is cost-effective because chip-based synthesis is cheaper than conventional synthesis, and the replication process generates large quantities from minimal templates

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent segments the oligonucleotide production process into two distinct stages: (1) chip-based synthesis of a diverse template pool, and (2) selective rolling circle replication of specific templates. This segmentation allows optimization of each stage independently, achieving both cost-effectiveness and high quantity

Inventive Principle:
Principle #1Segmentation

4Manufacturing precision

If oligonucleotide pools contain truncated sequences, then synthesis completeness is improved, but folding reliability deteriorates

Engineering Contradiction:
Improvesequence completenessVSAvoidfolding reliability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent converts the presence of truncated sequences in chip-synthesized pools from a harmful factor into a beneficial selection process. By using rolling circle replication with specific primers, the method selectively amplifies only the complete, full-length oligonucleotide sequences, while truncated sequences remain unamplified and are effectively removed from the final product

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the cost-effective production of high-quality oligonucleotides in sufficient quantities for DNA nanostructure assembly, reducing defects and improving folding yields, while avoiding the interference of unwanted oligonucleotides.

Implementation Method 1

The invention provides compositions and methods for selective amplification of oligonucleotides from a larger oligonucleotide pool, as well as the resultant oligonucleotide pools and subpools. Embodiments of the invention are based, at least in part, on a nucleic acid amplification method, referred to as rolling circle replication.

Methodology Applied
Scientific EffectRolling circle replication:

Implementation Method 2

the subpool-specific region (1) comprises a subpool-specific sequence and an endonuclease site, and (2) is flanked at each end by a nicking site

Methodology Applied
Scientific EffectNicking:

Implementation Method 3

the subpool-specific region comprises a subpool-specific sequence and an endonuclease site

Methodology Applied
Scientific EffectEndonuclease cleavage:

Implementation Method 4

Two- and three-dimensional nanoscale shapes can be constructed from folding a long strand of DNA. This folding is based on the specificity of the interactions between complementary nucleotides.

Methodology Applied
Scientific EffectComplementary base pairing:

Data Source

PatentUS9862994B2Selective nucleic acid amplification from nucleic acid pools
Publication Date: 2018.01.09 DANA FARBER CANCER INSTITUTE INC
  • US9862994B2 patent drawing
  • US9862994B2 patent drawing
  • US9862994B2 patent drawing

AI summary

Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis.